Study Raises Questions About Prostate Cancer Therapies Targeting IGF-1
Thursday, May 1, 2008 - 06:21
in Health & Medicine
Therapies under development to treat prostate cancer by inhibiting the ability of insulin-like growth factor to activate its target receptor could have unexpected results especially if a major tumor suppressor gene -- p53 -- is already compromised.